Quantify the Effectiveness of CSTDs via Wipe Sampling
February 2017 : Oncology Safety - Vol. 14 No. 2 - Page #1

According to the Centers for Disease Control and Prevention (CDC), about 8 million US health care workers—including pharmacists, pharmacy technicians, nurses, providers, and environmental service workers—are potentially exposed to hazardous medications.1 The Occupational Safety and Health Administration (OSHA) has identified worker exposure to hazardous medications, which can occur during the drug preparation, administration, and disposal processes, as a problem of increasing health concern.2

Per USP General Chapter <800>, a closed system drug-transfer device (CSTD) mechanically prohibits both environmental contaminants from entering the system and the escape of hazardous medication or vapors from the system.3 The chapter states that CSTDs should be used when compounding hazardous medications and must be used when administering antineoplastic hazardous medications (when the dosage form allows).3 With the advent of USP <800>, implementing both CSTDs and an environmental wipe sampling program to verify containment are critical steps in the effort to ensure safe handling of hazardous medications.

You've reached the limit of what you can see this month without logging in. Please log in or create a free account.

WHERE TO FIND: Closed System Drug-Transfer Devices (CSTDs)

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

    Just answer the following quick question for your chance to win:

    To continue, you must either login or register: